Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy
Open Access
- 30 September 2003
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 8 (3), 412-424
- https://doi.org/10.1016/s1525-0016(03)00199-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Adenovirus RIDβ Subunit Contains a Tyrosine Residue That Is Critical for RID-Mediated Receptor Internalization and Inhibition of Fas- and TRAIL-Induced ApoptosisJournal of Virology, 2002
- Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancerOncogene, 2000
- Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigenJCI Insight, 2000
- Gene delivery from replication-selective viruses: arming guided missiles in the war against cancerJCI Insight, 2000
- Conditionally replicating herpes vectors for cancer therapyJCI Insight, 2000
- Series Introduction: Replication-selective microbiological agents: fighting cancer with targeted germ warfareJCI Insight, 2000
- Herpes Simplex Virus as an in Situ Cancer Vaccine for the Induction of Specific Anti-Tumor ImmunityHuman Gene Therapy, 1999
- Adenovirus proteins that subvert host defensesTrends in Microbiology, 1994
- Antineoplasic activity of parvovirusesJournal of Virological Methods, 1991
- Restricted replication of adenovirus type 2 in mouse balb/3T3 cellsArchiv für die gesamte Virusforschung, 1986